TITLE

Whole Blood in the Management of Hypovolemia Due to Obstetrical Hemorrhage

AUTHOR(S)
Hobbins, John C.
PUB. DATE
October 2009
SOURCE
Hospital Medicine Alert;Oct2009, Vol. 4 Issue 8, p61
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The concept of abandoning the use of whole blood in favor of packed cells for the treatment of hypovolemia in obstetric hemorrhage should be questioned in view of this study's suggestion of a lower rate of acute tubular necrosis in patients treated with whole blood.
ACCESSION #
46793948

 

Related Articles

  • TUMOR NECROSIS FACTOR ALPHA AND NITRIC OXIDE IN BLOOD CELLS SUPERNATANTS STIMULATED WITH DENGUE VIRUS. Perez, A. B.; García, G.; Sierra, B.; Alvarez, M.; Cabrera, M. V.; Valdés, L.; Vázquez, S.; Guzmán, M. G. // Revista VacciMonitor (Vacunología y Temas Afines);Oct2002, Vol. 11 Issue 4, p1 

    Dengue viruses are endemic in most tropical countries and responsible for epidemics involving up to 100 million cases of dengue fever (DF) and approximately 250000 cases of dengue hemorrhagic fever (DHF) annually. Several reports correlate the participation of proinflamatory cytokines as Tumor...

  • Hematology Pharmacology. James, Stacy H. // AACN Advanced Critical Care;Apr-Jun2009, Vol. 20 Issue 2, p177 

    The article discusses various medications that are used in treating hemostasis and coagulation. The various types of antithrombotic agents that are used to treat hemostasis and coagulation are mentioned, including anticoagulants, human blood stimulators and fibrinolytic agents. Information is...

  • Anaemia, microcytosis and sirolimus—is iron the missing link? Sofroniadou, Sofia; Kassimatis, Theodoros; Goldsmith, David // Nephrology Dialysis Transplantation;May2010, Vol. 25 Issue 5, p1667 

    Background. Sirolimus (SRL) has been implicated in the causation of post-transplantation anaemia (PTA). It also induces profound red blood cell (RBC) microcytosis, which is poorly understood.

  • Hyperleukocytosis and retinal hemorrhages after chemotherapy and filgrastim administration for peripheral blood progenitor cell mobilization. Salloum, E.; Stoessel, K.M.; Cooper, D.L. // Bone Marrow Transplantation;4/15/98, Vol. 21 Issue 8, p835 

    A 49-year-old man with mantle cell lymphoma received 2.5 g/m² of cyclophosphamide and 900 mg/m² of etoposide followed by 10/μg/kg/day of Filgrastim for PBPC mobilization. This was complicated by marked hyperleukocytosis and retinal hemorrhages. The patient's symptoms improved gradually...

  • Erythropoietic Growth Factors in Oncology-Associated Anemia Part 2: Contrasting Perspectives on Guidelines.  // Formulary;May2004 Supp, Vol. 39, p1 

    Part II. Focuses on the development and implementation of formulary decisions in oncology-associated anemia and the strategies for maintaining high guideline compliance, including therapeutic interchange and pharmacist-managed therapy. Etiology, treatment and outcomes of oncology-associated...

  • From battlefield to hospital: Researchers ponder broader role for drug designed to stop the bleeding. Byrd, Jonathan // Drug Formulary Review;Apr2007 Supplement, Vol. 23, p1 

    The article provides information on NovoSeven«, a blood derivative of recombinant factor VIIa which is derived from hamster cells and approved for uncontrolled bleeding episodes in hemophiliacs. Adverse effects of NovoSeven« include fever, hemorrhage, decreased fibrinogen, and...

  • Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis. Wang, Yini; Wang, Zhao; Wu, Lin; Zhang, Jia; Wang, Jingshi; Yan, Lijuan // Annals of Hematology;Dec2013, Vol. 92 Issue 12, p1695 

    The aim of this study was to investigate the effectiveness and safety in the treatment of thrombocytopenia in hemophagocytic lymphohistiocytosis (HLH) by recombinant human thrombopoietin (rhTPO). A prospective randomized study was conducted between March 2010 and December 2011 in 40 patients...

  • Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases. Mori, Minako; Tsunemine, Hiroko; Imada, Kazunori; Ito, Kiminari; Kodaka, Taiichi; Takahashi, Takayuki // Annals of Hematology;Jun2014, Vol. 93 Issue 6, p901 

    Since the late 1990s, Stenotrophomonas maltophilia ( S. maltophilia) has become one of the most common nonfermenting Gram-negative bacilli that cause opportunistic infection. Patients with hematologic diseases are the most risky candidate for S. maltophilia pneumonia or sepsis because of...

  • Inhibition of Platelet Adhesion to Collagen as a New Target for Antithrombotic Drugs. K. Vanhoorelbeke; H. Ulrichts; A. Schoolmeester; H. Deckmyn // Current Drug Targets - Cardiovascular & Haematological Disorders;Jun2003, Vol. 3 Issue 2, p125 

    Platelet adhesion to a damaged blood vessel is the initial trigger for arterial hemostasis and thrombosis. Platelets adhere to the subendothelium through an interaction with von Willebrand factor (VWF), which forms a bridge between collagen within the damaged vessel wall and the platelet...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics